CD44 and cancer: Another purpose of modifying with HA is that HA can specifically bind to the CD44 receptor.[35] The overexpression of CD44 in cancer cells would enable targeted therapy.[36] Figure S23 (Supporting Information) shows the FTIR spectra, where the characteristic C─O bond peak at 1041 cm−1 confirms the successful modification of HA on the surface of the NPs.